Deakin University
Browse

Experimental and Human Evidence for Lipocalin-2 (Neutrophil Gelatinase-Associated Lipocalin [NGAL]) in the Development of Cardiac Hypertrophy and heart failure

Download (2.73 MB)
Version 3 2024-06-18, 02:30
Version 2 2024-06-05, 23:40
Version 1 2021-11-24, 15:57
journal contribution
posted on 2024-06-18, 02:30 authored by Francine Z Marques, Priscilla R Prestes, Sean G Byars, Scott C Ritchie, Peter Wurtz, Sheila K Patel, Scott A Booth, Indrajeetsinh Rana, Yosuke Minoda, Stuart P Berzins, Claire L Curl, James R Bell, Bryan Wai, Piyush M Srivastava, Antti J Kangas, Pasi Soininen, Saku Ruohonen, Mika Kahonen, Terho Lehtimaki, Emma Raitoharju, Aki Havulinna, Markus Perola, Olli Raitakari, Veikko Salomaa, Mika Ala-Korpela, Johannes Kettunen, Maree McGlynn, Jason Kelly, Mary E Wlodek, Paul A Lewandowski, Lea M Delbridge, Louise M Burrell, Michael Inouye, Stephen B Harrap, Fadi J Charchar
Experimental and Human Evidence for Lipocalin-2 (Neutrophil Gelatinase-Associated Lipocalin [NGAL]) in the Development of Cardiac Hypertrophy and heart failure

History

Journal

Journal of the American Heart Association

Volume

6

Article number

e005971

Pagination

1-57

Location

Hoboken, N.J.

Open access

  • Yes

ISSN

2047-9980

eISSN

2047-9980

Language

eng

Publication classification

C1 Refereed article in a scholarly journal

Issue

6

Publisher

Wiley-Blackwell Publishing